
Bioorganic and Medicinal Chemistry Letters p. 1547 - 1552 (1996)
Update date:2022-08-02
Topics:
Woods, Keith W.
Brooks, Clint D. W.
Maki, Robert G.
Rodriques, Karen E.
Bouska, Jennifer B.
Young, Patrick
Bell, Randy L.
Carter, George W.
Reference FLAP inhibitors 1 and 2 were converted into the corresponding O-acetic acid oxime congeners 8 and 11a, respectively, resulting in potent, orally active, leukotriene biosynthesis inhibitors. An attempt to create a dual FLAP and direct 5-LO inhibitor by replacing the carboxylate group in 1 with the N-hydroxyurea pharmacophore did not provide superior inhibitors.
View MoreJiangxi Dongbang Pharmaceutical Co., Ltd.
Contact:+86-795-4433603, 4433388
Address:Fengxin Industrial Park, Fengxin County, Jiangxi Province, P.R.C
Contact:86-10-62664360
Address:Building 10,No.18 AnNingZhuang East Road, GuangHua Pioneer Park,HaiDian District, BeiJing China
Jiangsu Allyrise Pharmaceutical Co., Ltd.(expird)
Contact:+86-523-86818997
Address:Taizhou,Jiangsu Province,CHINA
ABA Chemicals (Shanghai) Limited
Contact:021- 5115 9199-232
Address:Suite 18D, #201 Ningxia Road,
QINGDAO DEVELOP chemistry Co.,Limited
Contact:+86-532-85807910
Address:98#Nanjing Road, Qingdao, China 266071
Doi:10.1248/cpb.33.4275
(1985)Doi:10.1080/00397919908086040
(1999)Doi:10.1016/j.tet.2006.07.007
(2006)Doi:10.1021/acs.joc.6b02102
(2016)Doi:10.1007/s12272-013-0006-9
(2013)Doi:10.1002/hlca.201200490
(2012)